Clinical Trial Update: Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating [C-11]-CS1P1 for inflammation in primary and secondary central nervous system malignancies, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Central Nervous System Cancer

Drugs mentioned

• [C-11]-CS1P1 (CS1P1 radiotracer for PET imaging of inflammation)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Central Nervous System Cancer, Brain Metastases | Phase 2 | Status: RECRUITING